These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27153545)

  • 1. Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis.
    Zhao S; Jiang T; Zhang L; Yang H; Liu X; Jia Y; Zhou C
    Oncotarget; 2016 Jun; 7(24):36065-36073. PubMed ID: 27153545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
    Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
    Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.
    Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y
    Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
    Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
    J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
    Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
    Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancer.
    Muto S; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Suzuki H; Gotoh M
    Int J Oncol; 2015 Dec; 47(6):2082-90. PubMed ID: 26460798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
    O'Callaghan DS; Rexhepaj E; Gately K; Coate L; Delaney D; O'Donnell DM; Kay E; O'Connell F; Gallagher WM; O'Byrne KJ
    Eur Respir J; 2015 Dec; 46(6):1762-72. PubMed ID: 26541534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer.
    Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Iwata T; Uramoto H; So T; Tanaka F
    Lung Cancer; 2013 Sep; 81(3):475-479. PubMed ID: 23891508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T-cells and micrometastasis in lymph nodes of stage I NSCLC.
    Hanagiri T; Fukumoto M; Koyanagi Y; Furutani Y; Tanaka F
    Anticancer Res; 2014 Dec; 34(12):7185-90. PubMed ID: 25503147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
    Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
    J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis.
    Shou J; Zhang Z; Lai Y; Chen Z; Huang J
    BMC Cancer; 2016 Aug; 16(1):687. PubMed ID: 27566250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.
    Gai XD; Song Y; Li C; Lei YM; Yang B
    Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis.
    Ma L; Li R; Liu X; Yu W; Tang Z; Shen Y; Tian H
    BMC Cancer; 2024 Jul; 24(1):815. PubMed ID: 38977962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
    Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
    Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive bioinformatics analysis of FOXP3 in nonsmall cell lung cancer.
    Zhu J; Li Z; Chen J; Li W; Wang H; Jiang T; Ma Y
    Medicine (Baltimore); 2022 Dec; 101(50):e32102. PubMed ID: 36550816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinicopathological and Prognostic Implications of FoxP3
    Xu P; Fan W; Zhang Z; Wang J; Wang P; Li Y; Yu M
    Front Physiol; 2017; 8():950. PubMed ID: 29209232
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Peng C; Wang B; Li Y; Yang G
    Int J Clin Exp Pathol; 2014; 7(8):4685-94. PubMed ID: 25197340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.
    Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL
    Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.